Russell Investments Group, Ltd. Sarepta Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 125,096 shares of SRPT stock, worth $13.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

125,096

Previous 121,754 2.74%

Holding current value

$13.6 Million

Previous $19.2 Million 18.78%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $415,510 - $523,858	3,342 Added 2.74%	125,096 $15.6 Million
Q2 2024 Aug 08, 2024	SELL	$113.33 - $163.85 $643,147 - $929,848	-5,675 Reduced 4.45%	121,754 $19.2 Million
Q1 2024 May 08, 2024	BUY	$93.7 - $141.53 $391,572 - $591,453	4,179 Added 3.39%	127,429 $16.5 Million
Q4 2023 Feb 05, 2024	SELL	$67.31 - $124.76 $492,372 - $912,619	-7,315 Reduced 5.6%	123,250 $11.9 Million
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $512,500 - $617,950	-5,000 Reduced 3.69%	130,565 $15.8 Million
Q2 2023 Aug 10, 2023	SELL	$106.4 - $157.19 $2.4 Million - $3.55 Million	-22,602 Reduced 14.29%	135,565 $15.5 Million
Q1 2023 May 09, 2023	BUY	$117.53 - $155.99 $277,605 - $368,448	2,362 Added 1.52%	158,167 $21.8 Million
Q4 2022 Feb 08, 2023	BUY	$100.86 - $132.13 $1.02 Million - $1.33 Million	10,064 Added 6.91%	155,805 $20.2 Million
Q3 2022 Nov 04, 2022	BUY	$75.71 - $119.24 $4.3 Million - $6.77 Million	56,793 Added 63.85%	145,741 $16.1 Million
Q2 2022 Jul 29, 2022	SELL	$62.69 - $88.44 $574,741 - $810,817	-9,168 Reduced 9.34%	88,948 $6.67 Million
Q1 2022 May 05, 2022	BUY	$63.15 - $90.42 $635,289 - $909,625	10,060 Added 11.42%	98,116 $7.66 Million
Q4 2021 Jan 21, 2022	BUY	$77.28 - $99.42 $4.54 Million - $5.84 Million	58,758 Added 200.55%	88,056 $7.93 Million
Q3 2021 Nov 08, 2021	SELL	$65.97 - $92.48 $231,818 - $324,974	-3,514 Reduced 10.71%	29,298 $2.71 Million
Q2 2021 Aug 04, 2021	SELL	$69.38 - $86.75 $282,515 - $353,246	-4,072 Reduced 11.04%	32,812 $2.55 Million
Q1 2021 May 10, 2021	BUY	$72.25 - $168.95 $1.51 Million - $3.53 Million	20,884 Added 130.53%	36,884 $2.74 Million
Q4 2020 Feb 08, 2021	SELL	$125.56 - $178.74 $21,470 - $30,564	-171 Reduced 1.06%	16,000 $2.73 Million
Q3 2020 Nov 09, 2020	SELL	$127.12 - $172.34 $136,399 - $184,920	-1,073 Reduced 6.22%	16,171 $2.27 Million
Q2 2020 Aug 05, 2020	BUY	$93.0 - $171.7 $115,971 - $214,109	1,247 Added 7.8%	17,244 $2.77 Million
Q1 2020 May 06, 2020	SELL	$82.38 - $131.64 $57,666 - $92,147	-700 Reduced 4.19%	15,997 $1.57 Million
Q4 2019 Jan 29, 2020	BUY	$76.53 - $135.58 $135,381 - $239,841	1,769 Added 11.85%	16,697 $2.15 Million
Q3 2019 Nov 01, 2019	BUY	$72.81 - $156.91 $66,621 - $143,572	915 Added 6.53%	14,928 $1.12 Million
Q2 2019 Aug 09, 2019	SELL	$112.21 - $151.95 $270,762 - $366,655	-2,413 Reduced 14.69%	14,013 $2.13 Million
Q1 2019 May 13, 2019	BUY	$106.67 - $151.68 $149,231 - $212,200	1,399 Added 9.31%	16,426 $1.96 Million
Q4 2018 Feb 11, 2019	SELL	$97.32 - $148.76 $218,191 - $333,519	-2,242 Reduced 12.98%	15,027 $1.64 Million
Q3 2018 Oct 26, 2018	SELL	$115.31 - $161.51 $3.74 Million - $5.23 Million	-32,398 Reduced 65.23%	17,269 $2.79 Million
Q2 2018 Aug 08, 2018	SELL	$71.74 - $153.69 $206,324 - $442,012	-2,876 Reduced 5.47%	49,667 $6.57 Million
Q1 2018 May 11, 2018	SELL	$54.02 - $82.27 $137,534 - $209,459	-2,546 Reduced 4.62%	52,543 $3.89 Million
Q4 2017 Feb 06, 2018	SELL	$47.64 - $56.75 $1.25 Million - $1.49 Million	-26,321 Reduced 32.33%	55,089 $3.12 Million
Q3 2017 Nov 07, 2017	BUY	$35.73 - $47.15 $2.91 Million - $3.84 Million	81,410	81,410 $3.69 Million

Others Institutions Holding SRPT

# of Institutions

528

Shares Held

84M

Call Options Held

1.99M

Put Options Held

1.36M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.55B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Sarepta Therapeutics, Inc. Transaction History